CYTOO has worldwide exclusivity for adhesive cell micropatterns

27 April 2009

CYTOO Cell Architects has entered into an exclusive worldwide license agreement for the adhesive micropattern patent portfolio from the Curie Institute and the CNRS. The company has also solidified its freedom to operate commercially with signed patent license agreements with the CEA (Life Sciences Division) and Harvard University. Following execution of these licenses, CYTOO immediately launched the CYTOOchips as its first product on the research market.

Download info